Six healthy, scientifically informed human volunteers were given "C-labeled polyethyleneimine (PEI) microcapsules by mouth. Fecal "4C recovery was inversely related to mean gut transit time (r = -0.66), and the extent of cross-linking between the membrane andcore PEI was inversely related to total fecal output (r = -0.81). Cross-linking ofPEI microcapsules may be a biomonitor of endogenous cross-linking agents within the human gastrointestinal tract. Extensive loss of [4CWCH3 label occurd from the microcapsules during human trnst and in vitro fermentations with human fecal flora.
Introduction
The importance of diet (1) and the high contribution from gastrointestinal (GI) sites to human cancer risk (2) , have prompted us to devise a biomonitoring technique for the GI cavity (3) . This system consists of an oral dose of aqueous suspension of millions of magnetically recoverable, semipermeable microcapsules with a tough nylon membrane enclosing a polyamine, polyethyleneimine (PEI). Previous studies in rodents have shown that PEI microcapsules trapped alkylating agents (4) , Nnitrosating agents (5) , mutagens/carcinogens having planar molecular structure (6, 7) , and bifunctional alkylating (crosslinking) agents (8 (9) .
One milliliter of the '4C-labeled microcapsules was diluted with 3 mL ethanol, transferred to gelatin capsules, and administered to six healthy, nonsmoking, scientifically informed subjects (five men, one woman, age range 26-59 years), together with 200 radio-opaque markers (ROM) (10) , also in gelatin capsules. Baseline spot urines and stool specimens were collected by all the subjects immediately before administration of the microcapsules. After taking the microcapsules, subjects collected all fecal specimens, which were X-rayed to count the ROM, until all ROM had been recovered, and for a further 3 days. Urine samples were collected for 4-6 days and were checked for their completeness using p-aminobenzoic acid (PABA) (11 ) .
Fecal samples were individually digested with 10% aqueous tured by an ultrasonicator with Ti probe (four 15-sec periods with ice cooling), as reported previously (8) . From the resulting suspension, a 100-1.L aliquot was taken to measure total radioactivity (core and membrane) and the remainder centrifuged to separate for 14C counting the core (supernatant) and membrane (pellet) fractions. The extent of cross-linking of microcapsule core PEI to membrane PEI by endogenous agents was assessed from alteration relative to an aliquot of unused (control) microcapsules of the ratio:
(membrane "4C) (core 14C + membrane "4C)
To assess "4C loss of radioactivity, ethanol suspensions of microcapsules removed from feces were diluted with water and aliquots taken for Coulter counter assay and scintillation counting in Aquasol, so as to obtain their specific activity (dpm/-million). Results were compared with unused (control) microcapsules.
Results
Complete recovery of ROM was found from each subject (99 + 1%; range 196-200). The mean transit time of ROM through the gut (MTT) ranged from 26 hr in subject 5 to 106 hr in subject 3, and the radioactivity in individual fecal samples correlated well (r = 0.96) with the number of ROM recovered. In the last fecal sample from each volunteer (usually day 10), the measured radioactivity was at the baseline levels of the preadministration control fecal sample.
Recovery of radioactivity in the feces was 88 + 5 % of the administered dose and varied between subjects. The recovery of 14C dose in feces was inversely related to MTT through the gut (r = -0.66; Fig. 1 Total faecal output g FIGURE 2. Cross-linking in microcapsules in relation to total fecal output during the period of microcapsule excretion.
capsules was unrelated to the total "C fecal recovery (r = 0.23) and to MTT (r = 0.19). Comparison of losses for microcapsules on several consecutive days of excretion did not reveal any systematic increase of label loss with longer GI residence. There was no effect of length of time of GI residence on the size of microcapsules recovered from consecutive fecal samples.
In addition, the ratio (membrane '4C/total '4C) was increased more than 5-fold (from 6.8 to < 35), i.e., at least one-third ofcore PEI in the microcapsules had become cross-linked to the membrane by endogenous agents after transit through the gut. After correcting the cross-linking calculation for label loss in each specimen and correcting for the number of microcapsules recovered in each fecal specimen, cross-linking was found to be significantly and inversely related to stool weight, (r = -0.78) and to total fecal output (r = -0.81) (Fig. 2 ). There were no significant associations between cross-linking and transit time, nor between label loss and any colonic factor.
Discussion
There has been no previous method for monitoring reactive substances in the lower GI tract where unique biological conditions pertain, and it is perhaps not surprising that novel results were obtained from this first use of microcapsules. It is shown that these microcapsules can be passed through the human GI tract with a similar transit time to inert radio-opaque markers. The unchanged size distribution and lack of effect of gut residence time on microcapsule size distribution in successive stools are consistent with there being no preferential GI retention of smaller microcapsules.
The findings of substantial cleavage ofcovalently bound label from all microcapsules recovered from volunteers was surprise ing. Cleavage is presumed to occur in the colon because anaerobic incubation of microcapsules with mixed human fecal flora also demonstrated a substantial loss ofthe 14C label (9) . Loss of label has not been found in rats fed chow, but has been found in rats fed human diets, high in meat, fat and low in dietary fiber (9) . Microcapsules treated with H202 also lose "4C, exclusively from the core (8 In in vitro studies, the endogenous DNA-damaging agents fecapentaene-12 and 4-hydroxynonenal were shown to cause cross-linking in microcapsules (8) . The finding of substantial cross-linking after GI transit through humans indicates the presence of endogenous cross-linking agents within the human GI tract. Colon cancer risk is inversely associated with fecal weight in human populations, and there is a significant inverse relationship between cross-linking and fecal bulk found in this study (r = -0.81; Fig. 2 ). This, and the absence ofa relation between cross-linking and transit time, would suggest that crosslinking is related to proximity between the microcapsules and suspect cross-linking agents within the gastrointestinal tract, rather than extended length oftime ofresidence within the tract. A similar inverse relationship was found also between benzo[a]pyrene metabolite trapping and fecal bulk in F344 rats (12) .
